Jan 31st, 2022
A priority for EXCITE International is to bring payer and health system perspectives into the early stages of developing and evaluating new technologies. The present pathway to market is disjointed in that innovators focus on regulatory requirements, only to be subsequently rejected by payers because the evidence generated for regulatory purposes fails to address the concerns of payers and health systems. There are two reasons that innovators focus on regulatory requirements. First, regulato...